Original language | English (US) |
---|---|
Pages (from-to) | 29-35 |
Number of pages | 7 |
Journal | International Journal of Radiation Oncology Biology Physics |
Volume | 109 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2021 |
ASJC Scopus subject areas
- Radiation
- Oncology
- Radiology Nuclear Medicine and imaging
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: International Journal of Radiation Oncology Biology Physics, Vol. 109, No. 1, 01.01.2021, p. 29-35.
Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - Informed Consent in Radiation Oncology
AU - Gutiontov, Stanley I.
AU - Golden, Daniel W.
AU - McCloskey, Susan
AU - Shumway, Dean
AU - Sullivan, Donald R.
AU - Wall, Terry J.
AU - Gunderson, Leonard L.
AU - Jagsi, Reshma
N1 - Funding Information: Disclosures: D.G. is manager of RadOncQuestions LLC and HemOncReview LLC and has grant funding from the National Institutes of Health, Radiation Oncology Institute, and Bucksbaum Institute for Clinical Excellence. R.J. has stock options as compensation for her advisory board role in Equity Quotient, a company that evaluates culture in health care companies; she has received personal fees from Amgen and Vizient and grants for unrelated work from the National Institutes of Health, the Doris Duke Foundation, the Greenwall Foundation, the Komen Foundation, and Blue Cross Blue Shield of Michigan for the Michigan Radiation Oncology Quality Consortium; she has served as an expert witness for Sherinian and Hasso and Dressman Benzinger LaVelle. D.S., S.M., T.J.W., L.L.G., and S.G. have no conflicts of interest. Funding Information: Disclosures: D.G. is manager of RadOncQuestions LLC and HemOncReview LLC and has grant funding from the National Institutes of Health, Radiation Oncology Institute, and Bucksbaum Institute for Clinical Excellence. R.J. has stock options as compensation for her advisory board role in Equity Quotient, a company that evaluates culture in health care companies; she has received personal fees from Amgen and Vizient and grants for unrelated work from the National Institutes of Health, the Doris Duke Foundation, the Greenwall Foundation, the Komen Foundation, and Blue Cross Blue Shield of Michigan for the Michigan Radiation Oncology Quality Consortium; she has served as an expert witness for Sherinian and Hasso and Dressman Benzinger LaVelle. D.S., S.M., T.J.W., L.L.G., and S.G. have no conflicts of interest.
PY - 2021/1/1
Y1 - 2021/1/1
UR - http://www.scopus.com/inward/record.url?scp=85097660351&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097660351&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2020.08.064
DO - 10.1016/j.ijrobp.2020.08.064
M3 - Review article
C2 - 32911020
AN - SCOPUS:85097660351
SN - 0360-3016
VL - 109
SP - 29
EP - 35
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 1
ER -